 | • レポートコード：D005-17012 • 出版社/出版日：GlobalInfoResearch / 2020年5月26日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ゼローダの世界市場を広く調査・分析し、今後の市場展望をまとめております。ゼローダの種類別市場規模（500mg、150mg）、用途別市場規模（乳がん、大腸がん、胃がん）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Roche、Hetero、Hikma、Teva、Reliance Group、Mylan、Cipla、Hengrui Medicine ・地域別グローバル市場分析 2015年-2020年 ・ゼローダの北米市場（アメリカ、カナダ、メキシコ） ・ゼローダのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ゼローダのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ゼローダの南米市場（ブラジル、アルゼンチン） ・ゼローダの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：500mg、150mg ・用途別分析：乳がん、大腸がん、胃がん ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Xeloda market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Xeloda market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Xeloda market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Xeloda market has been segmented into
500 mg
150 mg
By Application, Xeloda has been segmented into:
Breast Cancer
Colorectal cancer
Stomach Cancer
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Xeloda market presented in the report. This section sheds light on the sales growth of different regional and country-level Xeloda markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Xeloda market.
The report offers in-depth assessment of the growth and other aspects of the Xeloda market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Xeloda Market Share Analysis
Xeloda competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Xeloda sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Xeloda sales, revenue and market share for each player covered in this report.
The major players covered in Xeloda are:
Roche
Hetero
Hikma
Teva
Reliance Group
Mylan
Cipla
Hengrui Medicine
Among other players domestic and global, Xeloda market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Xeloda product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Xeloda, with price, sales, revenue and global market share of Xeloda in 2018 and 2019.
Chapter 3, the Xeloda competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Xeloda breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Xeloda market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Xeloda sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Xeloda Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Xeloda Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 500 mg
1.2.3 150 mg
1.3 Market Analysis by Application
1.3.1 Overview: Global Xeloda Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Breast Cancer
1.3.3 Colorectal cancer
1.3.4 Stomach Cancer
1.4 Overview of Global Xeloda Market
1.4.1 Global Xeloda Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Roche SWOT Analysis
2.1.4 Roche Product and Services
2.1.5 Roche Xeloda Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Hetero
2.2.1 Hetero Details
2.2.2 Hetero Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Hetero SWOT Analysis
2.2.4 Hetero Product and Services
2.2.5 Hetero Xeloda Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Hikma
2.3.1 Hikma Details
2.3.2 Hikma Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Hikma SWOT Analysis
2.3.4 Hikma Product and Services
2.3.5 Hikma Xeloda Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Teva
2.4.1 Teva Details
2.4.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Teva SWOT Analysis
2.4.4 Teva Product and Services
2.4.5 Teva Xeloda Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Reliance Group
2.5.1 Reliance Group Details
2.5.2 Reliance Group Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Reliance Group SWOT Analysis
2.5.4 Reliance Group Product and Services
2.5.5 Reliance Group Xeloda Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Mylan
2.6.1 Mylan Details
2.6.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Mylan SWOT Analysis
2.6.4 Mylan Product and Services
2.6.5 Mylan Xeloda Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Cipla
2.7.1 Cipla Details
2.7.2 Cipla Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Cipla SWOT Analysis
2.7.4 Cipla Product and Services
2.7.5 Cipla Xeloda Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Hengrui Medicine
2.8.1 Hengrui Medicine Details
2.8.2 Hengrui Medicine Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Hengrui Medicine SWOT Analysis
2.8.4 Hengrui Medicine Product and Services
2.8.5 Hengrui Medicine Xeloda Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Xeloda Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Xeloda Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Xeloda Manufacturer Market Share in 2019
3.3.2 Top 6 Xeloda Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Xeloda Sales, Revenue and Market Share by Regions
4.1.1 Global Xeloda Sales and Market Share by Regions (2015-2020)
4.1.2 Global Xeloda Revenue and Market Share by Regions (2015-2020)
4.2 North America Xeloda Sales and Growth Rate (2015-2020)
4.3 Europe Xeloda Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Xeloda Sales and Growth Rate (2015-2020)
4.5 South America Xeloda Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Xeloda Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Xeloda Sales, Revenue and Market Share by Country
5.1.1 North America Xeloda Sales and Market Share by Country (2015-2020)
5.1.2 North America Xeloda Revenue and Market Share by Country (2015-2020)
5.2 United States Xeloda Sales and Growth Rate (2015-2020)
5.3 Canada Xeloda Sales and Growth Rate (2015-2020)
5.4 Mexico Xeloda Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Xeloda Sales, Revenue and Market Share by Country
6.1.1 Europe Xeloda Sales and Market Share by Country (2015-2020)
6.1.2 Europe Xeloda Revenue and Market Share by Country (2015-2020)
6.2 Germany Xeloda Sales and Growth Rate (2015-2020)
6.3 UK Xeloda Sales and Growth Rate (2015-2020)
6.4 France Xeloda Sales and Growth Rate (2015-2020)
6.5 Russia Xeloda Sales and Growth Rate (2015-2020)
6.6 Italy Xeloda Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Xeloda Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Xeloda Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Xeloda Revenue and Market Share by Regions (2015-2020)
7.2 China Xeloda Sales and Growth Rate (2015-2020)
7.3 Japan Xeloda Sales and Growth Rate (2015-2020)
7.4 Korea Xeloda Sales and Growth Rate (2015-2020)
7.5 India Xeloda Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Xeloda Sales and Growth Rate (2015-2020)
7.7 Australia Xeloda Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Xeloda Sales, Revenue and Market Share by Country
8.1.1 South America Xeloda Sales and Market Share by Country (2015-2020)
8.1.2 South America Xeloda Revenue and Market Share by Country (2015-2020)
8.2 Brazil Xeloda Sales and Growth Rate (2015-2020)
8.3 Argentina Xeloda Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Xeloda Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Xeloda Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Xeloda Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Xeloda Sales and Growth Rate (2015-2020)
9.3 Turkey Xeloda Sales and Growth Rate (2015-2020)
9.4 Egypt Xeloda Sales and Growth Rate (2015-2020)
9.5 South Africa Xeloda Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Xeloda Sales and Market Share by Type (2015-2020)
10.2 Global Xeloda Revenue and Market Share by Type (2015-2020)
10.3 Global Xeloda Price by Type (2015-2020)
11 Global Xeloda Market Segment by Application
11.1 Global Xeloda Sales Market Share by Application (2015-2020)
11.2 Global Xeloda Revenue Market Share by Application (2015-2020)
11.3 Global Xeloda Price by Application (2015-2020)
12 Market Forecast
12.1 Global Xeloda Sales, Revenue and Growth Rate (2021-2025)
12.2 Xeloda Market Forecast by Regions (2021-2025)
12.2.1 North America Xeloda Market Forecast (2021-2025)
12.2.2 Europe Xeloda Market Forecast (2021-2025)
12.2.3 Asia-Pacific Xeloda Market Forecast (2021-2025)
12.2.4 South America Xeloda Market Forecast (2021-2025)
12.2.5 Middle East & Africa Xeloda Market Forecast (2021-2025)
12.3 Xeloda Market Forecast by Type (2021-2025)
12.3.1 Global Xeloda Sales Forecast by Type (2021-2025)
12.3.2 Global Xeloda Market Share Forecast by Type (2021-2025)
12.4 Xeloda Market Forecast by Application (2021-2025)
12.4.1 Global Xeloda Sales Forecast by Application (2021-2025)
12.4.2 Global Xeloda Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Xeloda Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Xeloda by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Xeloda Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Roche Basic Information, Manufacturing Base and Competitors
Table 8. Roche Xeloda Major Business
Table 9. Roche Xeloda Total Revenue (USD Million) (2017-2018)
Table 10. Roche SWOT Analysis
Table 11. Roche Xeloda Product and Services
Table 12. Roche Xeloda Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Hetero Basic Information, Manufacturing Base and Competitors
Table 14. Hetero Xeloda Major Business
Table 15. Hetero Xeloda Total Revenue (USD Million) (2017-2018)
Table 16. Hetero SWOT Analysis
Table 17. Hetero Xeloda Product and Services
Table 18. Hetero Xeloda Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Hikma Basic Information, Manufacturing Base and Competitors
Table 20. Hikma Xeloda Major Business
Table 21. Hikma Xeloda Total Revenue (USD Million) (2017-2018)
Table 22. Hikma SWOT Analysis
Table 23. Hikma Xeloda Product and Services
Table 24. Hikma Xeloda Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Teva Basic Information, Manufacturing Base and Competitors
Table 26. Teva Xeloda Major Business
Table 27. Teva Xeloda Total Revenue (USD Million) (2017-2018)
Table 28. Teva SWOT Analysis
Table 29. Teva Xeloda Product and Services
Table 30. Teva Xeloda Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Reliance Group Basic Information, Manufacturing Base and Competitors
Table 32. Reliance Group Xeloda Major Business
Table 33. Reliance Group Xeloda Total Revenue (USD Million) (2017-2018)
Table 34. Reliance Group SWOT Analysis
Table 35. Reliance Group Xeloda Product and Services
Table 36. Reliance Group Xeloda Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Mylan Basic Information, Manufacturing Base and Competitors
Table 38. Mylan Xeloda Major Business
Table 39. Mylan Xeloda Total Revenue (USD Million) (2017-2018)
Table 40. Mylan SWOT Analysis
Table 41. Mylan Xeloda Product and Services
Table 42. Mylan Xeloda Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Cipla Basic Information, Manufacturing Base and Competitors
Table 44. Cipla Xeloda Major Business
Table 45. Cipla Xeloda Total Revenue (USD Million) (2017-2018)
Table 46. Cipla SWOT Analysis
Table 47. Cipla Xeloda Product and Services
Table 48. Cipla Xeloda Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 50. Hengrui Medicine Xeloda Major Business
Table 51. Hengrui Medicine Xeloda Total Revenue (USD Million) (2017-2018)
Table 52. Hengrui Medicine SWOT Analysis
Table 53. Hengrui Medicine Xeloda Product and Services
Table 54. Hengrui Medicine Xeloda Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Global Xeloda Sales by Manufacturer (2018-2019) (K MT)
Table 56. Global Xeloda Revenue by Manufacturer (2018-2019) (USD Million)
Table 57. Global Xeloda Sales by Regions (2015-2020) (K MT)
Table 58. Global Xeloda Sales Market Share by Regions (2015-2020)
Table 59. Global Xeloda Revenue by Regions (2015-2020) (USD Million)
Table 60. North America Xeloda Sales by Countries (2015-2020) (K MT)
Table 61. North America Xeloda Sales Market Share by Countries (2015-2020)
Table 62. North America Xeloda Revenue by Countries (2015-2020) (USD Million)
Table 63. North America Xeloda Revenue Market Share by Countries (2015-2020)
Table 64. Europe Xeloda Sales by Countries (2015-2020) (K MT)
Table 65. Europe Xeloda Sales Market Share by Countries (2015-2020)
Table 66. Europe Xeloda Revenue by Countries (2015-2020) (USD Million)
Table 67. Asia-Pacific Xeloda Sales by Regions (2015-2020) (K MT)
Table 68. Asia-Pacific Xeloda Sales Market Share by Regions (2015-2020)
Table 69. Asia-Pacific Xeloda Revenue by Regions (2015-2020) (USD Million)
Table 70. South America Xeloda Sales by Countries (2015-2020) (K MT)
Table 71. South America Xeloda Sales Market Share by Countries (2015-2020)
Table 72. South America Xeloda Revenue by Countries (2015-2020) (USD Million)
Table 73. South America Xeloda Revenue Market Share by Countries (2015-2020)
Table 74. Middle East & Africa Xeloda Sales by Countries (2015-2020) (K MT)
Table 75. Middle East & Africa Xeloda Sales Market Share by Countries (2015-2020)
Table 76. Middle East & Africa Xeloda Revenue by Countries (2015-2020) (USD Million)
Table 77. Middle East & Africa Xeloda Revenue Market Share by Countries (2015-2020)
Table 78. Global Xeloda Sales by Type (2015-2020) (K MT)
Table 79. Global Xeloda Sales Share by Type (2015-2020)
Table 80. Global Xeloda Revenue by Type (2015-2020) (USD Million)
Table 81. Global Xeloda Revenue Share by Type (2015-2020)
Table 82. Global Xeloda Sales by Application (2015-2020) (K MT)
Table 83. Global Xeloda Sales Share by Application (2015-2020)
Table 84. Global Xeloda Sales Forecast by Regions (2021-2025) (K MT)
Table 85. Global Xeloda Market Share Forecast by Regions (2021-2025)
Table 86. Global Xeloda Sales Forecast by Type (2021-2025) (K MT)
Table 87. Global Xeloda Market Share Forecast by Type (2021-2025)
Table 88. Global Xeloda Sales Forecast by Application (2021-2025)
Table 89. Global Xeloda Market Share Forecast by Application (2021-2025)
Table 90. Direct Channel Pros & Cons
Table 91. Indirect Channel Pros & Cons
Table 92. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Xeloda Picture
Figure 2. Global Sales Market Share of Xeloda by Type in 2019
Figure 3. 500 mg Picture
Figure 4. 150 mg Picture
Figure 5. Xeloda Sales Market Share by Application in 2018
Figure 6. Breast Cancer Picture
Figure 7. Colorectal cancer Picture
Figure 8. Stomach Cancer Picture
Figure 9. Global Xeloda Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Xeloda Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Xeloda Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Xeloda Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Xeloda Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Xeloda Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Xeloda Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Xeloda Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Xeloda Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Xeloda Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Xeloda Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Xeloda Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Xeloda Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Xeloda Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Xeloda Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Xeloda Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Xeloda Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Xeloda Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Xeloda Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Xeloda Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Xeloda Sales Market Share by Manufacturer in 2019
Figure 30. Global Xeloda Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Xeloda Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Xeloda Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Xeloda Sales and Growth Rate (2015-2020) (K MT)
Figure 35. Global Xeloda Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Xeloda Revenue Market Share by Regions (2015-2020)
Figure 37. Global Xeloda Revenue Market Share by Regions in 2018
Figure 38. North America Xeloda Sales and Growth Rate (2015-2020)
Figure 39. Europe Xeloda Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Xeloda Sales and Growth Rate (2015-2020)
Figure 41. South America Xeloda Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Xeloda Sales and Growth Rate (2015-2020)
Figure 43. North America Xeloda Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Xeloda Sales Market Share by Countries (2015-2020)
Figure 45. North America Xeloda Sales Market Share by Countries in 2018
Figure 46. North America Xeloda Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Xeloda Revenue Market Share by Countries in 2018
Figure 48. United States Xeloda Sales and Growth Rate (2015-2020) (K MT)
Figure 49. Canada Xeloda Sales and Growth Rate (2015-2020) (K MT)
Figure 50. Mexico Xeloda Sales and Growth Rate (2015-2020) (K MT)
Figure 51. Europe Xeloda Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Xeloda Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Xeloda Revenue Market Share by Countries in 2019
Figure 54. Germany Xeloda Sales and Growth Rate (2015-2020) (K MT)
Figure 55. UK Xeloda Sales and Growth Rate (2015-2020) (K MT)
Figure 56. France Xeloda Sales and Growth Rate (2015-2020) (K MT)
Figure 57. Russia Xeloda Sales and Growth Rate (2015-2020) (K MT)
Figure 58. Italy Xeloda Sales and Growth Rate (2015-2020) (K MT)
Figure 59. Asia-Pacific Xeloda Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Xeloda Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Xeloda Revenue Market Share by Regions 2019
Figure 62. China Xeloda Sales and Growth Rate (2015-2020) (K MT)
Figure 63. Japan Xeloda Sales and Growth Rate (2015-2020) (K MT)
Figure 64. Korea Xeloda Sales and Growth Rate (2015-2020) (K MT)
Figure 65. India Xeloda Sales and Growth Rate (2015-2020) (K MT)
Figure 66. Southeast Asia Xeloda Sales and Growth Rate (2015-2020) (K MT)
Figure 67. South America Xeloda Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Xeloda Sales Market Share by Countries in 2019
Figure 69. South America Xeloda Revenue Market Share by Countries in 2019
Figure 70. Brazil Xeloda Sales and Growth Rate (2015-2020) (K MT)
Figure 71. Argentina Xeloda Sales and Growth Rate (2015-2020) (K MT)
Figure 72. Middle East and Africa Xeloda Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Xeloda Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Xeloda Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Xeloda Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Xeloda Sales and Growth Rate (2015-2020) (K MT)
Figure 77. Egypt Xeloda Sales and Growth Rate (2015-2020) (K MT)
Figure 78. Turkey Xeloda Sales and Growth Rate (2015-2020) (K MT)
Figure 79. South Africa Xeloda Sales and Growth Rate (2015-2020) (K MT)
Figure 80. Global Xeloda Sales and Growth Rate (2021-2025) (K MT)
Figure 81. Global Xeloda Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Xeloda Market Forecast (2021-2025) (K MT)
Figure 83. Europe Sales Xeloda Market Forecast (2021-2025) (K MT)
Figure 84. Asia-Pacific Sales Xeloda Market Forecast (2021-2025) (K MT)
Figure 85. South America Sales Xeloda Market Forecast (2021-2025) (K MT)
Figure 86. Middle East & Africa Sales Xeloda Market Forecast (2021-2025) (K MT)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
大腸がんの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Colorectal Cancer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.1% in the forecast period of 2020 to 2025 and will expected to reach USD 9118.8 million by 2025, from USD 8386.1 million in 2019. The Colorectal Cancer …- 大腸がん診断＆治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Colorectal Cancer Diagnosis and Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The …
- 転移性大腸がん手術の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Metastatic Colorectal Cancer Surgery market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Metastat…
- 乳がん検診の世界市場 2020年：メーカー別、地域別、種類・用途別 Summary Market Overview The global Breast Cancer Screening market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.0% in the forecast period of 2020 to 2025 and will expected to reach USD 2352.1 million by 2025, from USD 1726.4 million in 2019. The Brea…
- 肛門がん及び結腸直腸がんの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Anal and Colorectal Cancer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anal and Colorecta…